ea0029p631 | Diabetes | ICEECE2012
Pramod S
Issues: Newer anti-diabetic therapies out of reach of >84% populations of Asia. Pharmaceuticals donot provide price discounts in resource-constrained-countries. incidence of insulin resistance neglected issue in resource-poor nations. Diabetes forums failed to address this concern. Hence we formed liaison study group of four clinics to analyse this issue and make policy paper. Resource poor nations have little technical expertise/manpower to study insulin resistance. Lack ...